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Glomerular epithelial cell, polyanion neutralization is associated with
enhanced prostanoid production. We have studied the effect of neutral-
izing the surface charge of rat glomerular epithelial cells (GEC) in
culture on prostanoid production. Incubation of rat GEC with polyca-
tions poly-L-lysine (PL) resulted in a dose dependent increase of
6-keto-PGF1 (up to 8 to 10-fold) and PGE2 (up to 7 to 8-fold)
production. Other polycations such as protamine sulfate (PS) and
lysozyme (LY) produced a similar effect. The stimulation of
prostaglandin (PG) production by PL treated GEC was prevented by
the addition of polyanions such as bovine serum albumin (BSA) and
heparin (HP). The effect of PL on prostaglandin (PG) synthesis by GEC
was suppressed by the cyclooxygenase inhibitor sulindac sulfide. Ad-
dition of exogenous arachidonic acid (C20 :4) increased the basal
production of PG and under these conditions the effect of PL was
masked. We conclude that neutralization of the surface charge of rat
GEC by polycations results in profound increase of prostanoid synthe-
sis. The polycation caused increase in PG synthesis appears to be the
result of increased availability of intracellular C20: 4.
Evidence from experimental models of glomerular injury
suggests that both immune and nonimmune pathologic events
may be associated with an alteration in the intraglomerular
production of various prostanoids [reviewed in 1]. Another
pathogenetic aspect of glomerular damage is alteration of the
anionic properties of the cellular and structural components of
the glomerular capillary loops. Insults which diminish the
polyanionic properties of the glomerulus have been associated
with alteration in the permselectivity characteristics of the
filtration membrane and consequent proteinuria [21. Events
which alter the anionic charge of the glomerular epithelial cell
may also explain changes in the shape of that cell which are
seen in many pathologic conditions associated with proteinuria
[21. In order to determine the possible relationship between
insults which may neutralize the glomerular cell surface
polyanion and alterations of prostanoid synthesis in various
pathologic states, we have studied the effect of neutralization of
the cell surface charge of cultured, glomerular epithelial cells
upon prostaglandin synthesis.
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Methods
Cultures of rat glomerular epithelial cells
Cloned glomerular epithelial cells were grown to confluence
in 24 well—culture dishes (Corning, Midfield, Massachusetts,
USA) using the medium described by Kreisberg, Hoover and
Karnovsky [3]: RPMI-1640 medium buffered with 15 mri N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES,
GIBCO, Grand Island, New York, USA) supplemented with
20% fetal bovine serum (heat inactivated) and diluted in half
with conditioned medium (Dulbecco's modified Eagle's me-
dium + 10% heat—inactivated fetal call serum) from Swiss
mouse 3T3 cells, plus 0.66 U/ml of insulin, 100 U/ml of
penicillin and 100 sg/ml of streptomycin. This will be hence-
forth referred to as medium. The culture dishes were incubated
at 37°C in an atmosphere of 95% air and 5% CO2. The medium
was changed every third day. The characteristics of these cells
have been described before [3].
Radioimmunoassay of prostaglandins (PG) and
thromboxane (Tx)
PGE2, 6-keto-PGF1c. (the stable hydration product of PGI2)
and TxB2 (the stable hydration product of TxA2) were measured
by previously described RIA techniques [4—6]. Unextracted
samples of media were diluted in the standard diluent of the
assay (0.02 M P04 buffer, pH 7.4) and assayed in a volume of 1.5
ml at a final dilution of 1:6 to 1:60. The assay uses 5,000 cpm of
[3H]PGE2, [3H] 6-keto-PGF1a, [3H} TxB2 (New England Nu-
clear, Boston, Massachusetts, USA; 150 Ci/mM) and guinea pig
anti-PGE2, rabbit anti-6-keto-PGF1a and anti-TxB2 diluted
1:60,000, 1:160,000 and 1:400,000, respectively. The lowest
detectable concentration that could be measured with 95%
confidence was I pglml of PGE2, 2 pg/ml of 6-keto-PGF1a and 2
pg/ml of TxB2. Therefore, the detection limit of the assay was 6
pg/mI for PGE2, 12 pg/ml for 6-keto-PGF1a and TxB2. The
specificities of antisera employed in our RIA system are de-
scribed in detail elsewhere [4—6].
All experiments were performed at 37°C and in atmosphere of
95% air and 5% CO2. Cells were used between the third and
fifteenth passages. PGE2, 6-keto-PGF1c. and TxB2 were mea-
sured when cells reached confluency and formed a monolayer.
Culture dishes were washed three times with 1 ml of RPMI
medium containing HEPES buffer. One ml of RPMI containing
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Addition PGE2 6-Keto-PGF1. TXB2
None 0.15 0.07 (42) 0.44 0.25 (45) ND (4)
Sulindac sulfide
1 p.g/ml ND (4) ND (4)
C20:4
3 pg/mi 7.12 1.25a (8) 25.9 11.7° (8) ND (4)
C20:4 plus sulindac
I pg/mI 1.05 0.04° (4) 1.01 0.1° (4)
the experimental substances (C20 :4, sulindac suiphide) was
then added to the cells, followed by incubation for 60 minutes.
C20:4 (Sigma), 3 g/ml, was solubilized in ethanol; sulindac
sulfide was solubilized in dimethyl sulfoxide (DMSO). Appro-
priate ethanol, DMSO, and medium controls were used. At the
end of incubation period, culture medium was collected, frozen
and kept at —20°C until assayed for PGE2, 6-keto-PGF1a and
TxB2. PG synthesis was expressed as nanograms per milligram
of cell protein per 60 minutes. Cells were dissolved in 0.1%
sodium dodecyl sulfate (SDS) and protein content was deter-
mined by modification of the method of Lowry et al [7].
Statistical comparisons were made using the unpaired Student's
t-test.
Polycation treatment of glomerular epithelial cells
For these experiments cells were washed three times with 1
ml of glucose veronal buffer containing 0.15 M glucose, 3 mM
veronal, 0.1% gelatin, pH 7.35 (GVB). One milliliter of GVB
containing poly-L-lysine (molecular weight 3500, p1 > 10.5,
purity of 98.4%, Sigma No. P-0879, Sigma Chemical Co. St.
Louis, Missouri, USA), or lysozyme (molecular weight 14,300,
p110.5, Sigma No. L-6876), or protamine sulphate (approxi-
mate molecular weight 7000, p1> 10.5, Eli Lilly and Company,
Indianapolis, Indiana, USA), was then added to the cells
followed by incubation for 60 minutes. The time course of effect
of maximal doses of polylysine (100 igIml) on PG synthesis was
examined; significant stimulation was found at five minutes and
maximal effect was seen between 30 and 60 minutes. Based on
these observations, all subsequent incubations with polycations
were carried out for 60 minutes. At the end of 60 minutes GVB
buffer was removed and discarded. Cells were then washed two
times with RPMI buffered with HEPES. One ml of medium was
added to the cells followed by a second incubation for 60
minutes. Experiments were performed employing the polyca-
tions (such as poly-L-lysine) in an initial period of incubation
only, and, in both periods of incubation. At the end of 60
minutes the media was collected, frozen, and stored at —20°C
until assayed for PG and TX.
To test the protective effect of polyanions such as bovine
serum albumin (BSA) and heparin, they were included in the
first incubation medium with the polycations. None of the
polycations or polyanions interfered with the radioimmunoas-
says.
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Fig. 1. PGE2 (U) and PGI2 (; 6-keto-PGF,) synthesis by rat glomer-
ular epithelial cells after treatment with increasing doses of poly-L-
lysine (PL). Each bar represents the mean SD. The numbers in
parentheses represent the number of observations. Value at each PL
concentration was compared with value at zero PL. P was <0.01 at
concentration of 5 g/ml and all higher concentrations.
Results
Prostaglandin synthesis profile in the rat glomerular epithelial
cells
Basal and C20 :4 stimulated PG synthesis by epithelial cells
are summarized in Table 1. PGI2, measured as the stable
hydration product 6-keto-PGF1, and PGE2 were found in
detectable amounts. PG!2 was the major product of arachidon-
ate cyclooxygenation under both basal and stimulated condi-
tions and was approximately three—fold higher than PGE2 (0.44
0.25 ng/mg protein/hour vs. 0.15 0.07). Following incuba-
tion with C20:4, the concentration of both 6-keto-PGF1a and
PGE2 increased approximately 60- and 50-fold, respectively
(25.9 11.7 ng/mg protein/hr. and 7.12 1.25, respectively).
TxB2, the stable hydration product of TxA2, was undetectable
either under basal conditions or after C20 :4 stimulation. Basal
6-keto-PGF1a and PGE2 production was completely suppressed
by sulindac sulfide (1 gIml), an inhibitor of cyclooxygenase;
6-keto-PGF1a and PGE2 syntheses were inhibited by 96% and
85%, respectively, when sulindac sulfide was added in the
presence of C20:4.
Effect of poly-L-lysine on prostaglandin synthesis by
glomerular epithelial cells
Figure 1 depicts the dose dependent effect of poly-L-lysine on
PG synthesis by glomerular epithelial cells. The lowest dose of
poly-L-lysine (5 g/ml) was effective in significantly stimulating
PG synthesis. A maximal seven to eightfold increase of PGE2
synthesis and eight to tenfold increase of 6-keto-PGF1a was
found with poly-L-lysine concentrations ranging between 25
and 100 g/ml. To test whether poly-L-lysine induced PG
production by glomerular epithelial cells was due to de nova
arachidonate cyclooxygenation, epithelial cells were incubated
with a maximal dose of poly-L-lysine (100 j.gIml) in the pres-
ence of sulindac sulfide (1 jig/mI) or in the presence of
Table 1. Baseline production of PG and TX by rat
glomerular epithelial cells
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Data are expressed as ng/mg protein/hr and are represented as mean
SD. The numbers in parenthesis represent the number of observa-
tions. Abbreviations are: ND, not detectable; C20:4, arachidonic acid.
P < 0.01 compared to basal production without any additive.
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Table 2. Effect of arachidonic acid and sulindac sulfide on poly-L-lysine induced stimulation of PG synthesis by rat glomerular epithelial cells
exogenous arachidonate (Table 2). Sulindac sulfide inhibited
poly-L-lysine stimulated 6-keto-PGF1a production by 98% (6.11
2.11 nglmg protein/hr vs. 0.15 0.02) and completely
suppressed PGE2 synthesis. C20:4 increased PGE2 level 30-fold
and 6-keto-PGF1 level 40-fold. Combination of C20 :4 and
poly-L-lysine did not stimulate the synthesis of PGE2 and
6-keto-PGF1 above that caused by C20 :4 alone. The increase
of PG level in glomerular epithelial cells was seen whether the
cells were exposed to poly-L-lysine during the first incubation
only or during both periods of incubation. Poly-L-lysine did not
cause cell detachment or affect cell viability at any of the above
concentrations when tested by trypan blue exclusion.
In order to study the nature of the binding of poly-L-lysine to
the epithelial cell surface, glomerular epithelial cells were
incubated in the presence of two polyanions, native bovine
serum albumin and heparin. Inclusion of bovine serum albumin
(1 mg/mI) in the first incubation step along with poly-L-lysine
significantly reduced the poly-L-lysine mediated stimulation of
POE2 by 60% at poly-L-lysine concentrations of 25 tg/ml (P <
0.01), 37% at 50 g/ml (P < 0.01) and 20% at 100 g/ml.
6-Keto-PGF1a production was significantly reduced by 70% at
poly-L-ly sine concentration of 25 g/ml, 43% when the concen-
tration was 50 g/ml and remained unchanged at a poly-L-lysine
concentration of 100 ig/ml (Fig. 2). Addition of increasing
doses of heparin produced a dose—dependent inhibition of the
effect of poly-L-lysine (100 g/ml) on PGE2 and 6-keto-PGF1a
production by glomerular epithelial cells (Fig. 3). The lowest
dose of heparin (0.5 U/mi) tested in the experiment was capable
of inhibiting the effect of poly-L-lysine on both PGE2 and
6-keto-PGF1, production by approximately 45%. A maximal
inhibition of 90% of PG synthesis was observed in presence of
5 U/mI of heparin.
Effect of other polycations on PG production by glomerular
epithelial cells
Incubation with protamine sulfate (100 tg/ml) resulted in a
highly significant increment in PGE2 and 6-keto-PGF1 produc-
tion: approximately three and ninefold, respectively (Fig. 4). A
less but still significant increase in PG synthesis was observed
after incubation of epithelial cells with lysozyme (102 41% for
First incubation Second incubation PGE2 6-Keto-PGF1 TXB2
Medium Medium 0.18 0.09 (70) 0.60 0.34 (70) ND (4)
Medium Sulindac sulfide
I p.gIml
ND (4) ND (4)
C20:4 C20:4 6.21 l.25a (8) 24.5 10.4 (8) ND (4)
3 p.g/ml 3 g/ml
Poly-L-lysine Medium 1.53 0.53a (34) 6.11 2.1P (45) ND (4)
100 g/ml
Poly-L-lysine Sulindac sulfide ND (4) 0.15 0.02 (4)
100 g/ml I pg/ml
Poly-L-lysine 100 pg/mI C20:4 5.57 0.53" (8) 24.9 84b (8) ND (4)
plus C20:4 3 pg/mi 3 pg/mI
Data are expressed as ng/mg protein/hr and represented as mean
Abbreviations are: ND, Not detectable; C20:4, arachidonic acid.
P < 0.01 compared to medium, medium alone value in the first row
b P = non-significant (P> 0.1) compared to the C20:4, C20:4 value in the third row
SD. The numbers in parenthesis represent number of observations.
PL
PL + BSA (1 mg/mI)
0 25 50 75 100
1.6
E 1.2
I
0.8
0.4
0
0
E
(:0. q>6o
0 25 50 75 100
PL, ttg/mI
Fig. 2. PGE2 (A) and 6-keto-PGF1,, (B) production by poly-L-iysine
(PL) preireated glomerular epithelial—celis in presence of bovine serum
albumin (BSA). Each point represents the mean SD of 8 observations.
In A, PL vs. PL + BSA were significantly different (P < 0.01) at 25 and
50 g/ml points. At 100 g/m1 P = NS. In B, PL vs. PL + BSA were
significantly different a 25 and 50 pg/mI points. At 100 pg/mI P = NS.
PL
PL + BSA (1 mg/mI)
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PGE2 and 209 19%, for 6-keto-PGF1 above control). These
effects were also reversible with heparin.
Discussion
In our experiments the profile of PG synthesis by cloned
homogeneous cultures of rat glomerular epithelial cells does not
substantially differ from that described previously by
Kreisberg, Karnovsky and Lawrence [8]. Cultured glomerular
epithelial cells used between the third and fifteenth passages
produced predominantly PGI2 and smaller amounts of PGE2.
We did not find any appreciable amount of TXB2 in the basal
state or after stimulation of PG synthesis with C20 :4. Exposure
of cells to poly-L-lysine caused a multifold increase in PG
synthesis. Both PGE2 and PGI2 were stimulated in a dose—
dependent manner over a wide range of poly-L-lysine concen-
trations. The poly-L-lysine effect on PG synthesis was attenu-
ated in the presence of known polyanions, albumin and heparin,
suggesting that the effect was due to PL binding to the anionic
charge on the cell surface. Stimulatory effect on PG synthesis
were also obtained with other polycations, protamine sulphate
and lysozyme substantiating that the effect is, indeed, the
consequence of cell surface negative—charge neutralization and
not a non-specific biological effect of poly-L-lysine alone. This
conclusion is also strengthened by recent findings from this
laboratory that poly-L-lysine causes a dose—dependent reduc-
tion of surface negative—charge potential (zeta potential) of
glomerular epithelial cells and complete neutralization of the
cell polyanion at the concentration of 160 p.g/ml 191.
Themechanism of the PL effect was investigated further. The
effect of poly-L-lysine on the synthesis of prostaglandins was
(8)
significantly reduced by sulindac sulfide—a known inhibitor of
cyclooxygenase. This suggested that the poly-L-lysine effect
was dependent upon the de novo synthesis of PG from its
precursor arachidonic acid. When the intracellular pool of
C20 :4 was raised by supplying exogenous C20:4 there was an
increase in the basal production of PG, and under these
conditions the poly-L-lysine effect was masked. The increase in
basal PG in the presence of exogenous C20:4 was much higher
than that elicited by the maximum concentration of poly-L-
lysine. When the maximum pool size of C20:4 was obtained by
exogenous C20:4 poly-L-lysine was unable to increase it any
further. This implies that poly-L-lysine action is mediated by
raising the endogenous levels of C20 :4, possibly by its direct
action on phospholipase A2. Shier, Dubourdieu and Durkin [10]
observed the stimulatory effect of poly-L-lysine and other
synthetic polycations on the release of arachidonic acid and
prostaglandins in cultures of 3T3 Swiss mouse fibroblasts. The
fibroblasts were different in an important aspect that only
poly-L-lysine of a molecular weight above 30,000 was stimula-
tory. Rat GEC, on the other hand, could be stimulated by
poly-L-lysines of molecular weight 3500 as reported herein.
Higher poly-L-lysines were not tested in rat GEC. Shier et al
could clearly show that the polycations caused an activation of
the phospholipid hydrolysis involving a Ca + dependent en-
zyme in their system. Whether a similar mechanism operates in
the GEC remains to be investigated.
Whether or not this biochemical alteration in C20 :4 metabo-
lism in GEC induced in vitro by charge neutralization may have
a counterpart in vivo remains a pertinent question. Recently
Remuzzi et a! have demonstrated a transient increase in PG
synthesis and a persistent increase in TxB2 production by
isolated glomeruli in adriamycin induced nephrosis [11]. The
pathological changes in the glomerulus in this model were
confined to the glomerular visceral epithelial—cell and included
fusion of foot processes, loss of epithelial polyanion, and
epithelial cell activation. No blood—borne cells were seen in the
glomerulus. The authors suggested that the epithelial cell was
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Fig. 4. PGE2 () and 6-keto-PGF1 () production by ratglomerular
epithelial cells after treatment with protamine sulfate (PS) or lysozyme
(LY). Each bar represents the mean SD. The numbers in parentheses
represent the number of observations. All four values were significantly
above control values at P < 0.01.
Heparin, u/mi
Fig. 3. Effect of increasing concentrations of heparin (HP) on PGE2
(E) and 6-keto-PGF1,, (L) production by poly-L-lysine (PL) pretreated
glomerular epithelial cells. The numbers in parentheses represent the
number of observations. At all concentrations of heparin comparison
with control (0 heparin) was statistically significant at P < 0.01.
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the most likely source of the altered prostanoid synthesis. The
loss of epithelial polyanion and fusion of foot processes have
been shown to be a result of charge neutralization [2] or reduced
synthesis of charged molecules such as sialic acid [12]. In this
model it is not known whether the histological changes are due
to charge neutralization or reduced synthesis of charged mole-
cules. While it is conceivable that adriamycin may induce the
synthesis of a polycation in a renal or an extra—renal cell
resulting in the histological and the biochemical changes seen,
the extrapolation to the in vivo model remains speculative. The
absence of TXB2 increase in our cell system may very well be
due to the irreversible loss of TXB2 production and therefore an
artifact of the culture system.
Despite the increasing evidence for enhanced intrarenal pro-
duction of PG and TX in a number of experimental as well as
clinical forms of glomerular injury, the cause and the cellular
source of prostanoid synthesis has remained controversial.
These cells could be infiltrating blood elements such as leuko-
cytes, monocytes and platelets, recruited and activated to
synthesize PG at the site of glomerular injury [13—15], as well as
glomerular mesangial and epithelial cells [8]. The latter intrinsic
glomerular cells could possibly be activated by complement
factors [16], oxygen radicals [17], or platelet activating factor
[18]. Loss of glomerular polyanion as well as increased renal
prostanoid synthesis have been also described in immune
mediated glomerulonephritis, such as, serum nephrotoxic ne-
phritis [19, 201 and lupus glomerulonephritis [21, 22]. Our
results suggest that neutralization of glomerular epithelial cell
surface charges may be a pathophysiologic mechanism contrib-
uting, at least in part, to altered C20:4 metabolism in some
forms of glomerular disease.
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